| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36310ab39fe797510fbf5c0408149b4f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 |
| filingDate |
2010-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46f5d1c47a5efa38ea8ee122f18d215a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a48126798911423d95900d4b5578c0e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26342a4acb0902f32f799b0bea174c6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8e39d217630ca5f729a7ab900951152
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e27b963454b4c319426f2f57237ff53a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1445db9ca693d4f801ee29396f0d68ab |
| publicationDate |
2012-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20120003854-A |
| titleOfInvention |
Rilusol aqueous suspension |
| abstract |
Physically and chemically stable aqueous suspensions of rilusol have been described along with their preparation. Such aqueous suspensions comprise rilusol in the form of particles and one or more wetting agents, preferably surfactants. Rilusol is present in an amount from about 0.1% to about 20% w / v and has an average particle size of less than 200 μm; Such suspensions lack the known local (oral) anesthetic effect of rilusol. |
| priorityDate |
2009-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |